Feasibility study assessing the ability of an insulin pump-controlling algorithm to minimize hypoglycemia and hyperglycemia in patients with type 1 diabetes in a clinical research setting.
This study is a non-randomized, uncontrolled feasibility study that looks to enroll people with type 1 diabetes who are currently using an insulin pump. During the subject's participation, the study staff will closely monitor the study subject in a clinical research center environment for approximately 30 hours, while controller algorithm determined insulin doses are delivered by an insulin pump, and utilizing continuous glucose monitoring results.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Adjustment of Insulin dosing during meal time
Samsum Diabetes Reserach Inst.
Santa Barbara, California, United States
UVA Diabetes Technology Center
Charlottesville, Virginia, United States
Evaluation of the performance of the HHM system response to meal insulin while the subject is under close medical supervision in the Clinical Research Center (CRC) setting.
Time frame: After subject is discharged from CRC, 1 week after enrolment
Number of Safety Events and any additional information that can be used for product development
Time frame: After subject is discharged from CRC, 1 week after enrolment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.